Zoetic Interntnl PLC

Exercise of Share Options

RNS Number : 3934T
Zoetic International PLC
25 March 2021
 

For immediate release

25 March 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Zoetic International plc

('Zoetic', the 'Company' or the 'Group')

 

Exercise of Share Options

 

Further to the announcement issued on 29 May 2020, Zoetic International plc (LSE: ZOE), the international CBD group, is pleased to announce that it has today issued 1,000,000 ordinary shares of 1 pence each ("Ordinary Shares") following the exercise of options, at an exercise price of 12 pence per Ordinary Share (the "Option Shares").

 

Application will be made to the London Stock Exchange for the Option Shares to be admitted to trading on the Main Market of the London Stock Exchange and the Standard Segment of the FCA Official List (" Admission ").  It is expected that Admission will become effective and that dealings in the Option Shares on the Main Market of the London Stock Exchange will commence on or around 30 March 2021.

 

On Admission, the Company will have 196,570,034 Ordinary Shares in issue, each with one voting right.  There are no shares held in treasury.  Therefore, the Company's total number of Ordinary Shares and voting rights will be 196,570,034 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

- Ends -

 

Publication on website

 

A copy of this announcement is also available on the Group's website at   www.zoeticinternational.com

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

[email protected]

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQZLFLFXLBBBK